Terms: = Breast cancer AND PSA AND Clinical Outcome
4 results:
1. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients.
Alix-Panabières C
Recent Results Cancer Res; 2012; 195():69-76. PubMed ID: 22527495
[TBL] [Abstract] [Full Text] [Related]
2. A multicenter phase II clinical trial of lapatinib (GW572016) in hormonally untreated advanced prostate cancer.
Sridhar SS; Hotte SJ; Chin JL; Hudes GR; Gregg R; Trachtenberg J; Wang L; Tran-Thanh D; Pham NA; Tsao MS; Hedley D; Dancey JE; Moore MJ
Am J Clin Oncol; 2010 Dec; 33(6):609-13. PubMed ID: 20042973
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptome profiling in clinical breast cancer: from 3D culture models to prognostic signatures.
Fournier MV; Martin KJ
J Cell Physiol; 2006 Dec; 209(3):625-30. PubMed ID: 17001673
[TBL] [Abstract] [Full Text] [Related]
4. Predictive laboratory diagnostics in oncology utilizing blood-borne cancer cells--current best practice and unmet needs.
Brandt BH; Schmidt H; de Angelis G; Zänker KS
Cancer Lett; 2001 Jan; 162 Suppl():S11-S16. PubMed ID: 11164185
[TBL] [Abstract] [Full Text] [Related]
